← Axsome Therapeutics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($27.2m) | ($28.9m) | ($31.0m) | ($68.3m) | ($102.9m) | ($130.4m) | ($187.1m) | ($239.2m) | ($287.2m) | ($183.2m) | — | |
| Depreciation | $20k | $43k | $49k | $37k | $24k | $76k | $263k | $459k | $532k | $503k | $2.9m | |
| Amortization of Debt Issuance Costs | ($65k) | — | ($26k) | — | $470k | $554k | $668k | $1.2m | $1.5m | $527k | — | |
| Amortization of Intangible Assets | — | — | — | — | — | — | $4.1m | $6.4m | $6.4m | $6.4m | — | |
| Share-based Payment Arrangement, Noncash Expense | $2.0m | $2.1m | $1.8m | $6.1m | $14.8m | $20.8m | $37.7m | $62.6m | $85.2m | $93.8m | $93.9m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | $176k | $532k | $1.8m | $4.0m | $7.1m | — | |
| Share-based Payment Arrangement, Expense | $2.0m | $2.1m | $1.8m | $6.1m | $14.8m | $20.8m | $37.7m | $63k | $85.2m | $93.8m | $93.9m | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | — | — | — | — | $37.7m | $57.1m | $47.2m | $82.5m | ($89.7m) | |
| Increase (Decrease) in Inventories | — | — | — | — | — | — | $1.3m | $8.2m | ($744k) | $10.7m | ($19.3m) | |
| Inventory Write-down | — | — | — | — | — | — | — | $0 | $0 | $0 | — | |
| Increase (Decrease) in Accounts Payable | $2.2m | ($646k) | $252k | $7.3m | $2.6m | ($355k) | $25.5m | $2.1m | $31.3m | ($6.5m) | $21.0m | |
| Net Cash Provided by (Used in) Operating Activities | ($21.3m) |
($26.5m)
-24.39%
|
($30.1m)
-13.53%
|
($46.4m)
-54.31%
|
($78.5m)
-69.18%
|
($108.2m)
-37.94%
|
($116.5m)
-7.66%
|
($145.1m)
-24.52%
|
($128.4m)
+11.49%
|
($93.4m)
+27.26%
|
($70.7m)
+24.28%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $105k | $10k | $33k | $16k | $46k | $308k | $702k | $582k | $270k | $480k | ($263k) | |
| Net Cash Provided by (Used in) Investing Activities | ($105k) | ($10k) | ($33k) | ($16k) | ($46k) | ($308k) | ($53.7m) | ($582k) | ($270k) | ($480k) | ($263k) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | — | — | $3.3m | $7.2m | $21.7m | — | — | — | — | $332.0m | ($404.4m) | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | ($1.2m) | — | — | — | — | ($10.4m) | — | |
| Proceeds from Issuance of Long-term Debt | $10.0m | — | — | $20.0m | $50.0m | — | — | — | — | — | $400.0m | |
| Proceeds from Issuance of Common Stock | — | $23.7m | $12.9m | $238.2m | $14.1m | $7.2m | $236.8m | $258.8m | $40.8m | $67.9m | $54.6m | |
| Net Cash Provided by (Used in) Financing Activities | $10.0m |
$23.9m
+139.61%
|
$10.0m
-57.99%
|
$252.4m
+2415.33%
|
$42.4m
-83.20%
|
$11.1m
-73.76%
|
$284.6m
+2456.96%
|
$331.0m
+16.32%
|
$57.8m
-82.53%
|
$101.5m
+75.42%
|
$75.2m
-25.90%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($11.4m) | ($2.6m) | ($20.1m) | $206.0m | ($36.1m) | ($97.4m) | $114.4m | $185.4m | ($70.8m) | $7.6m | $305.1m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | $200.8m | $386.2m | $315.4m | $322.9m | $305.1m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $33k | $317k | $380k | $1.1m | $1.0m | $4.4m | $6.3m | $12.4m | $30.7m | $59.6m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $47k | $865k | $772k | $1.3m | $2.1m | $4.6m | $7.7m | $16.7m | $19.7m | $14.6m | — | |
| Income Taxes Paid, Net | — | — | — | — | — | — | — | — | — | ($180k) | — | |
| Additional Financial Items | ||||||||||||
| General and Administrative Expense | $6.3m | $7.2m | $9.4m | $13.6m | $28.9m | $66.6m | — | — | $54.2m | $63.3m | — | |
| Goodwill | — | — | — | — | — | — | $10.3m | $12.0m | $12.0m | $12.0m | — | |
| Income Tax Expense (Benefit) | — | — | $0 | $0 | $0 | $0 | $0 | $960k | $85k | ($530k) | — | |
| Operating Expenses | $27.5m | $27.2m | $32.8m | $67.2m | $99.1m | $124.7m | — | — | — | — | — | |
| Operating Lease, Expense | — | — | — | — | — | $1.2m | $1.3m | $2.2m | — | — | — |